SIGA Technologies
SIGA
#7361
Rank
S$0.57 B
Marketcap
S$8.04
Share price
-2.21%
Change (1 day)
-0.58%
Change (1 year)

SIGA Technologies (SIGA) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$36.46 Million

According to SIGA Technologies's latest financial reports the company's total liabilities are S$36.46 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

SIGA Technologies - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$38.78 M-48.92%
2023-12-31S$75.93 M127.69%
2022-12-31S$33.34 M-38.96%
2021-12-31S$54.63 M106.09%
2020-12-31S$26.5 M-80.49%
2019-12-31S$0.13 B-1.07%
2018-12-31S$0.13 B-78.05%
2017-12-31S$0.62 B-3.59%
2016-12-31S$0.64 B-2.42%
2015-12-31S$0.66 B23.6%
2014-12-31S$0.53 B140.15%
2013-12-31S$0.22 B136.13%
2012-12-31S$94.88 M47.69%
2011-12-31S$64.24 M233.33%
2010-12-31S$19.27 M-26.83%
2009-12-31S$26.34 M154.31%
2008-12-31S$10.35 M34.28%
2007-12-31S$7.71 M-25.43%
2006-12-31S$10.34 M116.17%
2005-12-31S$4.78 M89.07%
2004-12-31S$2.53 M171.71%
2003-12-31S$0.93 M-18.28%
2002-12-31S$1.13 M-7.58%
2001-12-31S$1.23 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Emergent BioSolutions
EBS
S$1.13 B 3,023.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
S$64.92 M 78.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$1.73 B 4,652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
S$1.69 M-95.35%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S$1.08 B 2,866.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
S$2.81 B 7,627.58%๐Ÿ‡บ๐Ÿ‡ธ USA